{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:27:59Z","timestamp":1785338879914,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T00:00:00Z","timestamp":1375920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2013.298","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T15:09:51Z","timestamp":1375974591000},"page":"e763-e763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation"],"prefix":"10.1038","volume":"4","author":[{"given":"Y","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,8]]},"reference":[{"key":"BFcddis2013298_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archophthalmol.2009.9","volume":"127","author":"M Saylor","year":"2009","unstructured":"Saylor M, McLoon LK, Harrison AR, Lee MS . Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 2009; 127: 402\u2013406.","journal-title":"Arch Ophthalmol"},{"key":"BFcddis2013298_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0002-9394(00)00389-5","volume":"129","author":"AM Carlsson","year":"2000","unstructured":"Carlsson AM, Chauhan BC, Lee AA, LeBlanc RP . The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Am J Ophthalmol 2000; 129: 297\u2013301.","journal-title":"Am J Ophthalmol"},{"key":"BFcddis2013298_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/archopht.116.12.1591","volume":"116","author":"Y Lachkar","year":"1998","unstructured":"Lachkar Y, Migdal C, Dhanjil S . Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol 1998; 116: 1591\u20131594.","journal-title":"Arch Ophthalmol"},{"key":"BFcddis2013298_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/archopht.124.9.1230","volume":"124","author":"MB Sherwood","year":"2006","unstructured":"Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM et al. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Arch Ophthalmol 2006; 124: 1230\u20131238.","journal-title":"Arch Ophthalmol"},{"key":"BFcddis2013298_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ajo.2008.08.005","volume":"147","author":"K Ma","year":"2009","unstructured":"Ma K, Xu L, Zhang H, Zhang S, Pu M, Jonas JB . Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model. Am J Ophthalmol 2009; 147: 326\u2013331.","journal-title":"Am J Ophthalmol"},{"key":"BFcddis2013298_CR6","first-page":"65","volume":"40","author":"E Yoles","year":"1999","unstructured":"Yoles E, Wheeler LA, Schwartz M . Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Visual Sci 1999; 40: 65\u201373.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"BFcddis2013298_CR7","first-page":"216","volume":"296","author":"JE Donello","year":"2001","unstructured":"Donello JE, Padillo EU, Webster ML, Wheeler LA, Gil DW . Alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther 2001; 296: 216\u2013223.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFcddis2013298_CR8","first-page":"2074","volume":"42","author":"MP Lafuente","year":"2001","unstructured":"Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, Garcia-Aviles A, Miralles de Imperial J, Vidal-Sanz M . Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Visual Sci 2001; 42: 2074\u20132084.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"BFcddis2013298_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0006-8993(01)02759-7","volume":"913","author":"FA Ahmed","year":"2001","unstructured":"Ahmed FA, Hegazy K, Chaudhary P, Sharma SC . Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res 2001; 913: 133\u2013139.","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"BFcddis2013298_CR10","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","volume":"48","author":"L Wheeler","year":"2003","unstructured":"Wheeler L, WoldeMussie E, Lai R . Role of alpha-2 agonists in neuroprotection. Survey Ophthalmol 2003; 48 (Suppl 1): S47\u2013S51.","journal-title":"Survey Ophthalmol"},{"issue":"Suppl 2","key":"BFcddis2013298_CR11","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1177\/112067210101102S03","volume":"11","author":"LA Wheeler","year":"2001","unstructured":"Wheeler LA, Woldemussie E . Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma. Eur J Ophthalmol 2001; 11 (Suppl 2): S30\u2013S35.","journal-title":"Eur J Ophthalmol"},{"key":"BFcddis2013298_CR12","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1167\/iovs.08-2078","volume":"49","author":"CJ Dong","year":"2008","unstructured":"Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA . Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Visual Sci 2008; 49: 4515\u20134522.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"BFcddis2013298_CR13","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1523\/JNEUROSCI.16-19-05986.1996","volume":"16","author":"R Wen","year":"1996","unstructured":"Wen R, Cheng T, Li Y, Cao W, Steinberg RH . Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 1996; 16: 5986\u20135992.","journal-title":"J Neurosci"},{"key":"BFcddis2013298_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1017\/S0952523802191152","volume":"19","author":"RK Lai","year":"2002","unstructured":"Lai RK, Chun T, Hasson D, Lee S, Mehrbod F, Wheeler L . Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Visual Neurosci 2002; 19: 175\u2013185.","journal-title":"Visual Neurosci"},{"key":"BFcddis2013298_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/archopht.120.6.797","volume":"120","author":"H Gao","year":"2002","unstructured":"Gao H, Qiao X, Cantor LB, WuDunn D . Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 2002; 120: 797\u2013803.","journal-title":"Arch Ophthalmol"},{"key":"BFcddis2013298_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/emboj.2011.55","volume":"30","author":"Y Fujita","year":"2011","unstructured":"Fujita Y, Endo S, Takai T, Yamashita T . Myelin suppresses axon regeneration by PIR-B\/SHP-mediated inhibition of Trk activity. EMBO J 2011; 30: 1389\u20131401.","journal-title":"EMBO J"},{"key":"BFcddis2013298_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nn1102-1131","volume":"5","author":"G Dechant","year":"2002","unstructured":"Dechant G, Barde YA . The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131\u20131136.","journal-title":"Nat Neurosci"},{"key":"BFcddis2013298_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","volume":"10","author":"DR Kaplan","year":"2000","unstructured":"Kaplan DR, Miller FD . Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10: 381\u2013391.","journal-title":"Curr Opin Neurobiol"},{"key":"BFcddis2013298_CR19","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1038\/cddis.2011.85","volume":"2","author":"Y Fujita","year":"2011","unstructured":"Fujita Y, Takashima R, Endo S, Takai T, Yamashita T . The p75 receptor mediates axon growth inhibition through an association with PIR-B. Cell Death Dis 2011; 2: e198.","journal-title":"Cell Death Dis"},{"key":"BFcddis2013298_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainresbull.2006.09.005","volume":"71","author":"U Lonngren","year":"2006","unstructured":"Lonngren U, Napankangas U, Lafuente M, Mayor S, Lindqvist N, Vidal-Sanz M et al. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment. Brain Res Bull 2006; 71: 208\u2013218.","journal-title":"Brain Res Bull"},{"key":"BFcddis2013298_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10384-005-0253-5","volume":"49","author":"T Metoki","year":"2005","unstructured":"Metoki T, Ohguro H, Ohguro I, Mamiya K, Ito T, Nakazawa M . Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage. Jpn J Ophthalmol 2005; 49: 453\u2013461.","journal-title":"Jpn J Ophthalmol"},{"key":"BFcddis2013298_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1126\/science.1161566","volume":"322","author":"KK Park","year":"2008","unstructured":"Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway. Science (New York, NY) 2008; 322: 963\u2013966.","journal-title":"Science (New York, NY)"},{"key":"BFcddis2013298_CR23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF . Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond 2006; 361: 1545\u20131564.","journal-title":"Philos Trans R Soc Lond"},{"key":"BFcddis2013298_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature01176","volume":"420","author":"KC Wang","year":"2002","unstructured":"Wang KC, Kim JA, Sivasankaran R, Segal R, He Z . P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002; 420: 74\u201378.","journal-title":"Nature"},{"key":"BFcddis2013298_CR25","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/dvdy.22412","volume":"239","author":"T Huang","year":"2012","unstructured":"Huang T, Krimm RF . Developmental expression of Bdnf, Ntf4\/5, and TrkB in the mouse peripheral taste system. Dev Dyn 2012; 239: 2637\u20132646.","journal-title":"Dev Dyn"},{"key":"BFcddis2013298_CR26","first-page":"1229","volume":"11","author":"K Nakamura","year":"2005","unstructured":"Nakamura K, Harada C, Okumura A, Namekata K, Mitamura Y, Yoshida K et al. Effect of p75NTR on the regulation of photoreceptor apoptosis in the rd mouse. Mol Vision 2005; 11: 1229\u20131235.","journal-title":"Mol Vision"},{"issue":"Pt 4","key":"BFcddis2013298_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/brain\/aws053","volume":"135","author":"M Ueno","year":"2012","unstructured":"Ueno M, Hayano Y, Nakagawa H, Yamashita T . Intraspinal rewiring of the corticospinal tract requires target-derived brain-derived neurotrophic factor and compensates lost function after brain injury. Brain 2012; 135 (Pt 4): 1253\u20131267.","journal-title":"Brain"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2013298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2013298","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2013298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:02:20Z","timestamp":1672963340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2013298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,8]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8]]}},"alternative-id":["BFcddis2013298"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2013.298","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,8]]},"assertion":[{"value":"10 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}